11-09 :: September 2011
nanotimes
Companies Facts
dustrial companies. He will succeed Richard Archu- leta who is stepping down after leading the company for the past four years.
http://www.PlasticLogic.com Q
atar Solar Technologies (QSTec) will build a US$1 billion polysilicon manufacturing plant
in Ras Laffan Industrial City. The plant is expected to produce 8,000 metric tons of polysilicon per year. QSTec expects the facility to be operational in the second half of 2013.
http://www.qf.org.qa/joint-ventures/qatar-solar-technologies
“Quantum dots are light emitting materials made via a precisely-controlled chemical synthesis process. The sophisticated nature of the manufacturing pro- cess, coupled with the need for a skilled educated workforce, makes Massachusetts an ideal place to locate a high-volume Quantum Dot manufacturing facility,” said Jason Carlson, QD Vision CEO.
http://www.qdvision.com Q Q
D Vision, Inc., developer of nanotechnology- based optical products for displays and solid
state lighting, has relocated to a new, high-volume production facility in Lexington, Massachusetts to support new products launching in 2012. QD Visi- on occupies the entire building in Lexington, which houses the company’s global headquarters, as well as its production and development facilities.
QD Vision is currently working with several global consumer electronics companies that are building new products that employ its Quantum Light™ optics. For displays, QD Vision’s products provide greatly expanded color gamut simultaneously redu- cing manufacturing and operating costs while impro- ving system energy efficiency. For solid state lighting, its products enable LED lamps to produce incandes- cent-like, warm, white light with high efficiency.
uantum Materials Corporation (Pink Sheets: QTMM) and Nanoaxis, LLC announce the
formation of a technology alliance combining Quan- tum Materials tetrapod quantum dot mass produc- tion technology with Nanoaxis advanced research expertise and intellectual property in gene therapy biomedical nanotechnology. The aim of the alli- ance is to develop Tetrapod Quantum Dot based Cancer diagnostic kits and theranostic applications including Alzheimer‘s, Type 1 and Type 2 Diabetes, Breast Cancer and Major Depression.
Quantum Materials Corporation will develop spe- cialized quantum dots for Nanoaxis to functionalize with their proprietary biomedical nanomaterials for a multiplexing drug delivery platform for drug/gene therapy and diagnostic medical devices technologies. The technology alliance allows these technologies to be developed rapidly due to Quantum Materials‘ ability to create the highest quality quantum dots in quantities necessary to support multiple projects with timely deliveries.
The immediate goal is to develop a QD microarray device for detection, diagnosis and quantification of early cancers. The QD-MI device will be designed
19
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67